CNR Institute of Neuroscience, Vedano al Lambro, MB 20854, Italy.
CNR Institute of Neuroscience, Pisa 56124, Italy.
Brain. 2022 Aug 27;145(8):2849-2868. doi: 10.1093/brain/awac083.
Synaptic dysfunction is an early mechanism in Alzheimer's disease that involves progressively larger areas of the brain over time. However, how it starts and propagates is unknown. Here we show that amyloid-β released by microglia in association with large extracellular vesicles (Aβ-EVs) alters dendritic spine morphology in vitro, at the site of neuron interaction, and impairs synaptic plasticity both in vitro and in vivo in the entorhinal cortex-dentate gyrus circuitry. One hour after Aβ-EV injection into the mouse entorhinal cortex, long-term potentiation was impaired in the entorhinal cortex but not in the dentate gyrus, its main target region, while 24 h later it was also impaired in the dentate gyrus, revealing a spreading of long-term potentiation deficit between the two regions. Similar results were obtained upon injection of extracellular vesicles carrying Aβ naturally secreted by CHO7PA2 cells, while neither Aβ42 alone nor inflammatory extracellular vesicles devoid of Aβ were able to propagate long-term potentiation impairment. Using optical tweezers combined to time-lapse imaging to study Aβ-EV-neuron interaction, we show that Aβ-EVs move anterogradely at the axon surface and that their motion can be blocked through annexin-V coating. Importantly, when Aβ-EV motility was inhibited, no propagation of long-term potentiation deficit occurred along the entorhinal-hippocampal circuit, implicating large extracellular vesicle motion at the neuron surface in the spreading of long-term potentiation impairment. Our data indicate the involvement of large microglial extracellular vesicles in the rise and propagation of early synaptic dysfunction in Alzheimer's disease and suggest a new mechanism controlling the diffusion of large extracellular vesicles and their pathogenic signals in the brain parenchyma, paving the way for novel therapeutic strategies to delay the disease.
突触功能障碍是阿尔茨海默病的早期机制,随着时间的推移,它涉及大脑中越来越大的区域。然而,它是如何开始和传播的还不清楚。在这里,我们表明小胶质细胞释放的与大细胞外囊泡(Aβ-EVs)相关的淀粉样β蛋白在体外改变了神经元相互作用部位的树突棘形态,并损害了体外和体内的突触可塑性,在海马齿状回回路中。在将 Aβ-EV 注入小鼠海马齿状回后 1 小时,长时程增强作用在海马齿状回中受损,但在其主要靶区齿状回中没有受损,而 24 小时后,在齿状回中也受损,这表明长时程增强作用缺陷在两个区域之间传播。当将携带由 CHO7PA2 细胞自然分泌的 Aβ 的细胞外囊泡注入时,也获得了类似的结果,而单独的 Aβ42 或没有 Aβ 的炎性细胞外囊泡都不能传播长时程增强作用缺陷。通过使用结合延时成像的光镊研究 Aβ-EV-神经元相互作用,我们表明 Aβ-EVs 在轴突表面向前移动,并且它们的运动可以通过 annexin-V 涂层来阻断。重要的是,当 Aβ-EV 运动被抑制时,长时程增强作用缺陷沿海马-海马回路不会传播,这表明神经元表面的大细胞外囊泡运动参与了长时程增强作用缺陷的传播。我们的数据表明,大的小胶质细胞细胞外囊泡参与了阿尔茨海默病早期突触功能障碍的发生和传播,并提出了一种新的机制来控制大脑实质中大细胞外囊泡及其致病信号的扩散,为延迟疾病的新的治疗策略铺平了道路。